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Abstract
Background: In 2014 close to 10 million people living with HIV (PLWH) in sub-Saharan Africa were on highly active
anti-retroviral therapy (HAART). The incidence of non-communicable diseases has increased markedly in PLWH as
mortality is reduced due to use of HAART. Common mental disorders (CMD) are highly prevalent in PLWH. We
aimed to determine factors associated with probable CMD and depression, assessed by 2 locally validated screening
tools in a population with high prevalence of HIV in Harare, Zimbabwe.
Methods: We carried out a cross-sectional survey of a systematic random sample of patients utilizing the largest
primary health care facility in Harare. Adults aged ≥18 years attending over a 2-week period were eligible, excluding
those who were critically ill or unable to give written informed consent. Two locally validated screening tools the
Shona symptom questionnaire (SSQ-14) and the Patient Health Questionnaire (PHQ-9) were administered by trained
research assistants to identify probable CMD and depression.
Results: Of the 264 participants, 165 (62.5 %) were PLWH, and 92 % of these were on HAART. The prevalence of probable
CMD (SSQ14 > = 9) and depression (PHQ9 > = 11) were higher among people living with HIV than among those without
HIV (67.9 and 68.5 % vs 51.4 and 47.2 % respectively). Multivariable analysis showed female gender and recent negative
life events to be associated with probable CMD and depression among PLWH (gender: OR = 2.32 95 % CI:1.07–5.05;
negative life events: OR = 4.14; 95 % CI 1.17–14.49) and with depression (gender: OR = 1.84 95 % CI:0.85–4.02; negative life
events: OR = 4.93.; 95 % CI 1.31–18.50)
Conclusion: Elevated scores on self-report measures for CMD and depression are highly prevalent in this high HIV
prevalence population. There is need to integrate packages of care for CMD and depression in existing primary health
care programs for HIV/AIDS.
Keywords: Common mental disorders, Depression, HIV, Highly active antiretroviral therapy
Background
Common mental disorders (CMD) affect people across
the world with a global lifetime prevalence of 29 % [1].
Presenting as a mixture of somatic, anxiety, and depressive
symptoms [2], CMD increase the risk of developing both
non-communicable and communicable diseases [3].
Amongst people living with HIV (PLWH), CMD are a
leading cause of disability [4–7] and are known to hasten
HIV disease progression [8], particularly in LMIC [4, 6, 9]
where low levels of CMD detection at primary health care
level [10] are confounded by a large treatment gap for
CMD [11, 12]. In sub-Saharan Africa it is estimated that
there is one psychologist for every 2.5 million people, one
mental health nurse for every million people and one
psychiatrist for every 2 million people [13]. In contrast, in
high income countries the ratio of psychiatrists to the
population is estimated to be 1:10000 [14].
In recent years the development of interventions that
emphasize task-shifting as a way to address the treatment
gap for CMD has gained recognition [15–18] with specific
structured packages being developed and evaluated
[19–21]. The key elements of task-shifting involve the
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delegation of responsibilities to lower level cadres, often
non-professionals, to deliver services while the more
qualified professionals provide support and supervision
[22]. However, use of targeted task-shifting psychological
interventions to address CMD in PLWH requires a thor-
ough understanding of factors associated with CMD in this
population [4, 23], due partially to the need for greater
monitoring and supervision of work delivered by non-
specialists [24–26].
Much is known about factors associated with CMD in
non-HIV populations in LMIC [27–31], contrasting with
sparse data on CMD among PLWH [6]. In four LMIC,
namely India, Zimbabwe, Chile and Brazil, female gender,
poverty and recent life events were found to be common
correlates of CMD in non-HIV populations [29]. In other
parts of the world, correlates of CMD in PLWH include
death of a significant other [32], family history of mental ill-
ness, negative coping style, alcohol dependency, food inse-
curity [33] and recent negative life events [34, 35]. Other
studies from poor resource settings have found that CMD
in PLWH is correlated with trauma, posttraumatic stress
disorder (PTSD), stigma and social barriers such as peoples’
attitudes towards disabilities, physical and organizational
obstacles, however, these differences appear to be due
to a difference in the study setting and study population
[36–39].
Early studies of CMD in PLWH in Zimbabwe were
based on antiretroviral (ART) -naïve populations using
the Shona Symptom Questionnaire (SSQ-14) [40] as the
main outcome instrument. Findings were inconsistent,
with correlates of CMD including being female, having a
male partner who was older by 10 or more years, multi-
parity (having borne a number of children), and negative
life events [34, 41, 42].
The aim of this study was to determine the prevalence
and correlates of probable CMD in a primary health care
setting with a high prevalence of HIV, and to compare
these correlates of CMD by HIV status. The study was part
of the validation of screening tools for CMD in a popula-
tion with a high prevalence of HIV, which was preparatory
work for a randomized controlled trial of a psychological
intervention to reduce depression. The trial used the SSQ-
14 and the 9-item Patient Health Questionnaire (PHQ-9)
as primary and secondary outcome measures respectively.
Establishing the prevalence of CMD among primary health
care patients helped determine the possible duration of re-
cruitment of participants for the trial, and analysis of corre-
lates of CMD contributed towards the development of
appropriate interventions [43].
Methods
Study setting and population
The study was carried out in the largest HIV primary health
care clinic in Harare where up to 200 PLWH are seen daily.
The primary health facility, which runs a daily HIV clinic,
focuses mainly on prescribing ART and treating other HIV-
related conditions, whilst also catering for both adults and
children with non-HIV related conditions. All adults
aged ≥18 years presenting to the clinic during the 2-
week study period from 14th-30th October 2013 were
eligible for recruitment. Patients were excluded if they
were critically ill (being physically incapacitated), had a
psychotic episode at presentation, or were unable to
comprehend the consenting procedure or declined to
give written informed consent.
Study procedure
Study personnel (four research assistants, six LHWs and
four psychiatrists) attended a 2-week training using a
guide initially developed by the author (DC). The research
assistants were trained on data collection methods using
the socio-demographic forms and the screening tools.
While the project coordinators were trained in screening
of participants to minimize bias. The psychiatrists were
trained in the use of the structured clinical interview
(SCID-IV) through a discussion forum led by DC which
involved going through the diagnostic criteria, building
consensus on how to manage clinically severe cases dur-
ing the validation, and procedures for ensuring fidelity.
The referral pathways for participants meeting criteria for
major depression and other acute medical conditions was
that they should be seen by the medical officer first, for as-
sessment, before being referred to a tertiary psychiatric
facility if needed. A 2-day pilot of the full study procedure
was carried out after training of the entire study team.
Ethical considerations
Ethical approval was obtained from the Medical Research
Council of Zimbabwe (MRCZ/A/1732), and the Human
Research Ethics Committee of the Faculty of Health Sci-
ences, University of Cape Town (HREC Ref: 090/2014) and
the London School of Hygiene and Tropical Medicine (Ref
8457), and written informed consent was sought from all
participants in accordance with good clinical practice. All
participants requiring immediate attention due to severe
CMD were referred to an existing service for people with
psychological distress based on problem solving therapy
running at the clinic [44].
Recruitment and sample size
The clinic register of clients attending the clinic over the
study period was used as the sampling frame. Based on this
sampling frame, computer generated random numbers
were used to select participants waiting to be attended to at
the study site: random numbers were allocated to patients
based on their position in the clinic queue while waiting to
be attended to by the clinic nurse. This exercise was carried
out while all the patients were in the waiting room waiting
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to be triaged to nursing evaluation. All those selected were
sensitized, informed briefly about the study before they
were asked if they were willing to participate. All interested
were then given further details of the study and written
consent was sought from eligible adults, while those
not meeting the criteria outlined above were excluded
at this point. After obtaining written consent the socio-
demographic questionnaire and study tools which in-
cluded the SSQ-14 [40] and the PHQ-9 [45] were
administered by data collectors. It took approximately
15–20 min to administer tools to each participant.
The sample size (N = 264) was chosen to provide good
precision for the primary aim of the validation study, to es-
timate sensitivity and specificity for screening tools against
the gold standard (SCID), allowing for stratification by HIV
status. This sample size enables us to estimate a prevalence
of CMD of 28 % with good precision (95 % CI 22-34 %),
and to have 80 % power to detect odds ratio of 2.5 for an
exposure which is 50 % prevalent in the controls.
Study measures
Socio-demographic variables were measured using an
adapted locally developed questionnaire previously used
in similar studies where variables such as unemployment,
recent negative life events, poverty and female gender had
been found to be associated with CMD [30, 31, 34, 46].
Participants were asked about recent negative life events.
The list of possible negative life events was based on a
previous study [34] and focus group discussions with both
the lay health workers and participants utilizing a local
CMD based intervention [44]. These included life events
such as death in the family, physical assault, sexual assault,
forced eviction, an HIV diagnosis, and an illness resulting
in admission to a tertiary hospital of either the participant
or an immediate family member.
Screening tools
The Shona Symptom Questionnaire (SSQ14) was used as
the primary outcome measure for CMD screening. The
SSQ14 is a locally developed 14-item screening tool vali-
dated using exemplary cross cultural methods [40]). It
consists of 14 dichotomous questions based on how an
individual has been feeling in the past week. It has been
used previously in epidemiological studies in Zimbabwe
[41, 44, 47] and has sensitivity of 96 %, specificity of 83 %,
and positive predictive value and negative predictive value
of 66 and 83 % respectively, using a cut-off of ≥8 [40]. In
this study population, we found an optimal cut-off score
of > = 9 in a validation exercise carried out by senior doc-
tors in the Department of Psychiatry using the structured
clinical interview (SCID-IV) as the gold standard (results
not published - sensitivity and specificity at cut-off of > = 9
were 85.9 and 70.4 % respectively).
The 9-item Patient Health Questionnaire (PHQ-9) [45]
was the instrument used to screen for probable depres-
sion. The PHQ-9 is amongst the most commonly used
screening instrument for depression in LMIC [48], and
uses a Likert scale giving a score ranging from 0 to a max-
imum of 27 with each of the 9 items giving a response
ranging from: Not at all (0); Several days (1); More than
half the days (2); and Nearly every day (3), and a higher
score indicating more severe depression [45]. The PHQ-9
was validated during the formative stage of the current
study using the structured clinical interview of the diag-
nostic statistical manual (SCID-IV), and showed a sensi-
tivity of 84.6 % for depression and specificity of 68.7 %
against the SCID at a cut-off of > =11 (results not pub-
lished). We therefore used this validated cut-off score of
11 and above for moderate depression.
Statistical analysis
Data were entered directly into the study desk-top com-
puter by a data entry clerk using a predesigned data entry
program containing automated range checks, and data
cleaning was carried out at the end of each day. Data were
transferred to STATA version 13.0 for analysis. Analysis
was based on outcome measures of the SSQ-14 for CMD
and PHQ-9 for depression. Following tests for effect
modification of HIV status and factors associated with
CMD, results were presented stratified by HIV status.
Socio-demographic variables of the two groups (cases vs.
non-cases) meeting SSQ-14 and PHQ-9 criteria for CMD
and depression respectively were initially compared to es-
tablish differences. Variables with p < 0.15 on univariate
logistic regression analyses were included in multivariable
regression, to estimate adjusted odds ratios (OR) and 95 %
confidence intervals (CI).
Results
Characteristics of study participants
A total of 332 people were approached during the study
period. Of these 297 (89 %) were eligible, and 264 (89 %)
of those who were eligible gave consent to take part. Of
the 264 included in the study, 208 (79 %) were female and
155 (59 %) were married. The majority (237; 89 %) re-
ported experiencing a negative life event in the 6-month
period before the study. HIV was highly prevalent, with
165 (62.5 %) reported as living with HIV according to self-
reports confirmed with clinic HIV test records, while 72
(27 %) were HIV negative. A total of 27 (10 %) were un-
aware of their HIV status because they had never been
tested. All participants approached were forthcoming with
their HIV status. Of the 165 who were confirmed HIV
positive, almost all (92 %) were on HAART, with most of
these (85 %) on HAART for more than 6 months.
Table 1 show characteristics of the study population
by HIV status. People living with HIV were more likely
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to be female (75.2.% vs 24.8 %; p = 0.008), older (47.2 %
vs 26.4 % aged ≥40 years; p = 0.009), and divorced/
widowed (25.5 % vs 5.6 %; p = 0.001).
Association of probable CMD and depression by HIV status
The prevalence of probable CMD (SSQ14 ≥ 9) and de-
pression (PHQ9 ≥ 11) were higher among people living
Table 1 Characteristics of study participants by HIV statusa
Characteristic HIV positive (n = 165) HIV negative (n = 72) p-value
N % N %
Gender 0.008
Male 41 24.8 % 7 9.7 %
Female 124 75.2 % 65 90.3 %
Age group 0.009
< 30 26 16.1 % 22 32.4 %
30–39 59 36.6 % 28 41.2 %
40–49 56 34.8 % 12 17.6 %
50+ 20 12.4 % 6 8.8 %
Marital status 0.001
Married/steady 87 52.7 % 57 79.2 %
Divorced/widowed 42 25.5 % 4 5.6 %
Single 36 21.8 % 11 15.3 %
Education 0.21
Secondary or more 127 77.0 % 58 80.6 %
Primary or less 38 23.0 % 14 19.4 %
Current employment status 0.78
Unemployed 69 41.8 % 33 45.8 %
Permanent FT or PT 16 9.7 % 7 9.7 %
Casual/self-employed 80 48.5 % 32 44.4 %
Main income source 0.20
Own business/salary 96 58.2 % 35 48.6 %
Partner/family 58 35.2 % 34 47.2 %
No income 11 6.7 % 3 4.2 %
Suffer from chronic illness 0.49
No 86 52.1 % 41 56.9 %
Yes 79 47.9 % 31 43.1 %
Reason for clinic visit 0.02
Routine/family/antenatal 63 38.2 % 39 54.2 %
Other reason 102 61.8 % 33 45.8 %
Negative life events in last six months 0.15
No 13 7.9 % 10 13.9 %
Yes 152 92.1 % 62 86.1 %
SSQ ≥ 9 0.02
No 53 32.1 % 35 48.6 %
Yes 112 67.9 % 37 51.4 %
PHQ ≥ 11 0.002
No 52 31.5 % 38 52.8 %
Yes 113 68.5 % 34 47.2 %
aHIV status unknown (n = 27) not included
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with HIV than among those without HIV (67.9 and
68.5 % vs 51.4 and 47.2 % respectively; Table 1). On uni-
variable analyses, both probable CMD and depression
were associated with being female, and having experi-
enced negative life events (Table 2).
On multivariable analyses, female gender and negative
life events were independently associated with both
probable CMD and depression among participants with
HIV (Table 3). In addition, there was some evidence that
probably CMD was associated with having a chronic
medical condition (OR = 1.87, 95 % C I 0.92–3.81) and
that depression was associated with having less than sec-
ondary education (OR = 3.68, 95 % CI 1.35–10.07). The
small number of HIV negative participants reduced the
ability to look at associations in this group, but there
was some evidence that females were at higher risk of
probable CMD (OR = 3.05, 95 % CI 0.51–18.12) and
stronger evidence that less than secondary education
and negative life events were associated with depression
(OR = 5.69, 95 % CI 1.26–25.7 and OR = 9.42, 95 % CI
1.36–65.1, respectively)
Discussion
We found a high prevalence of probable CMD and de-
pression (both over 60 %) among PLWH, underpinning
the importance of detecting and addressing common
mental disorders in this population. Our results indicate
that probable CMD and depression in PLWH, as mea-
sured by the SSQ-14 and the PHQ-9, are associated with
recent negative life events and female gender. These
findings reflect those from non-HIV infected popula-
tions [29–31, 49]. In a recent systematic review of
screening tools used in LMIC, prevalence of 11 %–55 %
was reported, however, none of the studies looked at
HIV populations on ART [48]. While the risk of false
positive screening results from self-report measures is a
concern, such tools can contribute towards identifying
those most at risk of CMD in resource-poor settings
when validated and used within primary health care fa-
cilities [6, 7].
Although we did not measure adherence to HAART
in our study population, there is growing evidence of an
association of CMD and depression with poor adherence
to HAART [8, 50, 51]. There is also evidence suggesting
that treatment of depression increases adherence to
HAART [50, 52]. Despite being on HAART, PLWH face
a magnitude of problems and are twice as likely to suffer
from depression when compared to HIV negative matched
controls [34, 53, 54]. The findings of our study have impli-
cations for some of the newer WHO initiatives such as the
Option B+ [55] which advocate for immediate commence-
ment of HAART for HIV infected pregnant women. Over
30 % of women attending the Prevention of Mother to
Child Transmission of HIV (PMTCT) program in
Zimbabwe have signs of post-natal depression [34],
therefore the inclusion of CMD packages of care within
these initiatives is critical as this will contribute towards
improving outcomes for PLWH.
In LMIC the improvement of HAART access will need
to be matched with an equally focused integration of
evidence-based CMD and depression care packages [6]
because there is a large body of data showing that treat-
ing CMD among PLWH improves adherence to HAART
and quality of life [56–58]. Both HIV positive and HIV
negative women are more likely to be affected by CMD
and depression in our setting [29, 34]. Furthermore they
are more likely to utilize primary health care facilities
than their male counterparts [59]. Therefore focusing on
women who are living with HIV at primary health care
level, particularly those with negative life events who
screen positive on the SSQ-14 and PHQ-9 will strengthen
existing HIV related programs such as the PMTCT and
the newer Option B+. There is evidence showing the feasi-
bility of using screening tools at primary health care level
in Zimbabwe [34, 41, 44, 60] but these tools are not inte-
grated into HIV care programs.
There are several psychological interventions that have
been shown to work in LMIC, which could be adapted
for use among PLWH [61–64]. However, most of the
studies evaluating the effectiveness of these interventions
for PLWH have been of poor quality [25]. Therefore
there is a need to conduct rigorous formative research
to design interventions and evaluate them before they
are introduced or integrated into health care facilities in
LMIC. Part of this process should involve establishing
factors that are associated with CMD and depression,
and using this information to determine the content of
interventions for specific populations. Our findings sup-
port the use of a problem solving therapy approach
because of the strong association between negative life
events and CMD [65]. Problem solving therapy has shown
promising results in earlier pilot studies in Zimbabwe,
particularly among participants who have experienced
negative life events [44, 61]. It guides participants through
a process to list the problems (negative events) that they
face, select a problem to tackle based on the client’s prior-
ities, develop a specific and measurable way of addressing
the problem and execute an action plan aimed at address-
ing the problem while motivating and encouraging the
participant to be pro-active in the process [44].
There is evidence supporting the use of lay health
workers to deliver such interventions for CMD in LMIC
[24] with a number of well designed randomized con-
trolled trials suggesting that this is a cost-effective way
of addressing the treatment gap for MNS [21, 66–68].
Our study’s main limitation is the lack of data on HIV
staging and viral load markers. These factors can be
associated with increased risk of developing CMD and
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depression [69–71]. Although similar high rates of
CMD and depression have been reported from other
LMIC [6, 72], the use of a clinic-based sample of people
predominately visiting the clinic for physical ailments
reduces the generalizability of our findings. Further-
more, the use of screening tools without a gold stand-
ard to confirm diagnosis may result in the inclusion of
participants who are not actually clinically depressed
Table 2 Characteristics of HIV + participants by SSQ-14 and PHQ-9 scores
SSQ ≥ 9 PHQ ≥ 11
Univariable analysis Univariable analysis
Total N % OR 95 % CI p-value Total N % OR 95 % CI p-value
Gender 0.03 0.05
Male 41 53.7 % 1.00 - 41 56.1 % 1.00 -
Female 124 72.6 % 2.29 (1.10–4.74) 124 72.6 % 2.07 (1.00–4.31)
Age group 1.00 0.66
< 30 26 69.2 % 1.00 - 26 65.4 % 1.00 -
30–39 59 67.8 % 0.94 (0.35–2.53) 59 69.5 % 1.21 (0.45–3.21)
40–49 56 67.9 % 0.94 (0.34–2.56) 56 66.1 % 1.03 (0.39–2.74)
50+ 20 70.0 % 1.04 (0.29–3.69) 20 80.0 % 2.12 (0.54–8.26)
Marital status 0.75 0.37
Married/steady 87 65.5 % 1.00 - 87 66.7 % 1.00 -
Divorced/widowed 42 69.0 % 1.17 (0.53–2.59) 42 64.3 % 0.90 (0.42–1.95)
Single 36 72.2 % 1.37 (0.58–3.21) 36 72.8 % 1.75 (0.71–4.32)
Education 0.93 0.01
Secondary or more 127 67.7 % 1.00 127 63.8 % 1.00
Primary or less 38 68.4 % 1.03 (1.45–3.04) 38 84.2 % 3.03 (1.18–7.79)
Currently working? 0.53 0.86
Unemployed 69 71.0 % 1.00 - 69 69.6 % 1.00 -
Permanent FT or PT 16 56.3 % 0.52 (0.17–1.60) 16 62.5 % 0.73 (0.23–2.57)
Casual/self-employed 80 67.5 % 0.85 (0.42–1.71) 80 68.8 % 0.96 (0.48–1.93)
Main income source 0.51 0.17
Own business/salary 96 65.6 % 1.00 - 96 65.6 % 1.00 -
Partner/family 58 69.0 % 1.16 (0.58–2.34) 58 69.0 % 1.16 (0.58–2.34)
No income 11 81.8 % 2.36 (0.48–11.55) 11 90.9 % 5.24 (0.64–42.70)
Chronic medical condition 0.07 0.33
No 86 61.6 % 1.00 - 86 65.1 % 1.00 -
Yes 79 74.7 % 1.84 (0.94–3.58) 79 72.2 % 1.39 (0.72–2.69)
Suffer from other chronic illness 0.75 0.43
No 127 68.5 % 1.00 - 127 66.9 % 1.00 -
Yes 38 65.8 % 0.88 (0.41–1.91) 38 73.7 % 1.38 (0.61–3.11)
Negative life events 0.004 0.02
No 13 30.8 % 1.00 - 13 38.5 % 1.00 -
Yes 152 71.1 % 5.52 (1.62–18.87) 152 71.1 % 3.93 (1.22–12.67)
ARV medication 0.35 0.12
No 14 78.6 % 1.00 - 14 85.7 % 1.00 -
Yes 151 66.9 % 0.55 (0.15–2.06) 151 66.9 % 0.34 (0.07–1.56)
Disclosure to partner 0.78 0.44
No 69 66.7 % 1.00 - 69 65.2 % 1.00 -
Yes 96 68.8 % 1.10 (0.57–2.13) 96 70.8 % 1.30 (0.67–2.51)
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[73]. Nevertheless, our cut-off score was based on a val-
idation study conducted in Zimbabwe and provide an
indication of the likely margin of error on these mea-
sures. Studies utilizing clinical interviews have found
lower rates but these are still higher than those found
in non-HIV infected people [7]. In addition, data on the
type of HAART being taken by study participants was
not available. A number of HAART drugs can increase
the risk of psychiatric disorders including depression
[74–76]. Although education and employment have
been shown in previous studies to be associated with
CMD and depression, our study indicates that this was
not the case. This may have been due to the homogenous
nature of the study population recruited from the same
geographical location with similar socio-economic status.
The low uptake of male participants is consistent with pre-
vious studies carried out in primary health care facilities in
the country and other parts of the world [44, 77–79].
Conclusion
This study highlights, as in previous earlier studies in
non-HIV infected populations, the association of female
gender and negative life events with CMD and depres-
sion. Of note is the finding of high prevalence of these
disorders in PLWH on HAART. This highlights the
need to introduce interventions within HIV care clinics
at primary health care level aimed at addressing this
burden, which if left unchecked could negatively impact
the gains made in the fight against HIV/AIDS in the last
2 decades. We further recommend the use of a two-
stage screening process particularly where resources are
scarce to avoid the inclusion of false positives, with the
second stage consisting of a diagnostic screen. However,
in resource-poor settings with large numbers of LHWs a
greater sensitivity and a lower specificity would be rec-
ommended to ensure that all possible cases are included.
We further recommend that the Option B+ program be
administered with a psychological intervention. Further
studies are needed to look into the development of
multiple stage screening delivered by LHWs.
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